healthcare are mainly calibrated to measure whole blood. To minimize matrix effects of control materials in external quality assessment schemes, we stabilized fresh human EDTA-treated blood with sodium iodoacetate (1.8 mmol/ L). The whole-blood based control material was useful for control of hemoglobin and glucose, the two most common analyses in primary care, even after storage at room temperature for at least 10 days and at 5#{176}C for 3 weeks. The material was also useful for control of cholesterol and creatinine analyses for samples stored as long as 3 days at ambient temperature. 
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Received April 25, 1994; accepted September 9, 1994. both analyses would be valuable to avoid problems with matrix effects. In this study, we wanted to design such a stable whole-blood control medium for this purpose and to investigate its usefulness for other common analyses such as cholesterol (6, 9) and creatinine on the Reflotron analyzer. (Fig. 1) . The addition of fluoride significantly reduced the glucose concentration measured with the One Touch (P <0.05). The Accutrend gave a lower value for glucose than the other instruments did, whether stabilizers were present or not. Sample-to-sample variation seemed to be higher for the MediSense than for the other instruments.
Materials and Methods

Preparation
Influence of the stabilizers on hemoglobin measurements with selected analyzers. showed no significant changes during storage for 4 days at room temperature.
For five different patients' samples the mean recovery (four measurements on each sample each day) at room temperature was 100% (C.!. 97-104%) on the fourth day (initial mean cholesterol, 4.2 mmol/L). In the presence of iodoacetate the Reflotron creatinine measurements were stable 3 days at room temperature. The mean recovery for five patients' samples (four measurements on each sample each day) at room temperature was 101% (C.!. 98-105%) on the third day (initial mean creatinine, 99 tmoI/L).
Discussion
The most common biochemical analyses in general practice in Europe are measurements of glucose, hemoglobin, and cholesterol (3, 6, 9). For glucose measurements many instruments, based on various principles, are available.
Although many of these were intended for home monitoring by diabetics the apparatuses are also used in primary care, in hospital nursing departments, and for outpatients. Five samples, measured four times each on the same day.
crease in the glucose concentration cannot be avoided when these stabilizers are used (13). Consequently, the glucose target value determined by the internal comparison method in the control laboratory should first be performed after 4-6 h and preferably after 2 days, to best match the testing time by the practitioners. 
